FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116798103> ?p ?o ?g. }

• W2116798103 endingPage "2166" @default.
• W2116798103 startingPage "2159" @default.
• W2116798103 abstract "Triple-negative breast cancer comprises 10% to 15% of newly diagnosed breast cancer and lacks expression of the estrogen, progesterone, and human epidermal growth factor receptor 2/neu receptors. Many such tumors are basal like, a molecular intrinsic subtype of breast cancer associated with poor clinical outcomes. Patients with early-stage basal-like triple-negative breast cancer are at a high risk for relapse and may, therefore, benefit from novel therapies, including immunotherapy. MUC1 is a tumor antigen expressed on adenocarcinomas and represents an ideal target for MUC1-based vaccination. We evaluated 52 cases of early-stage basal-like triple-negative breast cancer for MUC1 expression by immunohistochemistry. The intensity of staining was graded according to the intensity (negative [0], positive [1], or strongly positive [2]) and percentage (0%-100%) of tumor cells staining for MUC1. An overall score of 0 to 2.0 was calculated for each case by multiplying the intensity of staining by the percentage of tumor cells staining positively. Four staining patterns for MUC1 were identified: apical, cytoplasmic, membranous, and combination. Of the 52 cases of basal-like triple-negative breast cancers, 49 (94%) were positive for MUC1 expression. The mean score was 0.90 (range, 0-1.9). Cases were evenly distributed over this range, where most (67%) exhibited moderate to strong MUC1 expression (score, 0.5-1.90), 27% demonstrated weak MUC1 expression, and 6% lacked MUC1 expression. There was a significant difference in MUC1 score and percent MUC1+ cells in favor of the combination pattern. This study indicates that a large proportion of early-stage basal-like triple-negative breast cancer expresses MUC1 and provides a rationale for MUC1-based immunotherapy in this high-risk patient cohort." @default.
• W2116798103 created "2016-06-24" @default.
• W2116798103 creator A5018592399 @default.
• W2116798103 creator A5030160317 @default.
• W2116798103 creator A5032203137 @default.
• W2116798103 creator A5040266504 @default.
• W2116798103 creator A5059061070 @default.
• W2116798103 creator A5067152062 @default.
• W2116798103 creator A5088253295 @default.
• W2116798103 date "2013-10-01" @default.
• W2116798103 modified "2023-09-24" @default.
• W2116798103 title "MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer" @default.
• W2116798103 cites W1506961604 @default.
• W2116798103 cites W1541668845 @default.
• W2116798103 cites W1701849548 @default.
• W2116798103 cites W1964978938 @default.
• W2116798103 cites W1989663680 @default.
• W2116798103 cites W2009481222 @default.
• W2116798103 cites W2012300394 @default.
• W2116798103 cites W2014733698 @default.
• W2116798103 cites W2025574132 @default.
• W2116798103 cites W2033881546 @default.
• W2116798103 cites W2035077913 @default.
• W2116798103 cites W2044567178 @default.
• W2116798103 cites W2060099765 @default.
• W2116798103 cites W2070480410 @default.
• W2116798103 cites W2091221538 @default.
• W2116798103 cites W2097255042 @default.
• W2116798103 cites W2102850350 @default.
• W2116798103 cites W2111429259 @default.
• W2116798103 cites W2118842085 @default.
• W2116798103 cites W2126843107 @default.
• W2116798103 cites W2131994307 @default.
• W2116798103 cites W2138929540 @default.
• W2116798103 cites W2155587856 @default.
• W2116798103 cites W2157840751 @default.
• W2116798103 doi "https://doi.org/10.1016/j.humpath.2013.04.010" @default.
• W2116798103 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4167755" @default.
• W2116798103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23845471" @default.
• W2116798103 hasPublicationYear "2013" @default.
• W2116798103 type Work @default.
• W2116798103 sameAs 2116798103 @default.
• W2116798103 citedByCount "61" @default.
• W2116798103 countsByYear W21167981032013 @default.
• W2116798103 countsByYear W21167981032014 @default.
• W2116798103 countsByYear W21167981032015 @default.
• W2116798103 countsByYear W21167981032016 @default.
• W2116798103 countsByYear W21167981032017 @default.
• W2116798103 countsByYear W21167981032018 @default.
• W2116798103 countsByYear W21167981032019 @default.
• W2116798103 countsByYear W21167981032020 @default.
• W2116798103 countsByYear W21167981032021 @default.
• W2116798103 countsByYear W21167981032022 @default.
• W2116798103 countsByYear W21167981032023 @default.
• W2116798103 crossrefType "journal-article" @default.
• W2116798103 hasAuthorship W2116798103A5018592399 @default.
• W2116798103 hasAuthorship W2116798103A5030160317 @default.
• W2116798103 hasAuthorship W2116798103A5032203137 @default.
• W2116798103 hasAuthorship W2116798103A5040266504 @default.
• W2116798103 hasAuthorship W2116798103A5059061070 @default.
• W2116798103 hasAuthorship W2116798103A5067152062 @default.
• W2116798103 hasAuthorship W2116798103A5088253295 @default.
• W2116798103 hasBestOaLocation W21167981032 @default.
• W2116798103 hasConcept C121608353 @default.
• W2116798103 hasConcept C126322002 @default.
• W2116798103 hasConcept C142724271 @default.
• W2116798103 hasConcept C143998085 @default.
• W2116798103 hasConcept C204232928 @default.
• W2116798103 hasConcept C2777421810 @default.
• W2116798103 hasConcept C2778024521 @default.
• W2116798103 hasConcept C2779306644 @default.
• W2116798103 hasConcept C2780110267 @default.
• W2116798103 hasConcept C530470458 @default.
• W2116798103 hasConcept C71924100 @default.
• W2116798103 hasConcept C74864618 @default.
• W2116798103 hasConcept C84606932 @default.
• W2116798103 hasConcept C86803240 @default.
• W2116798103 hasConcept C98717036 @default.
• W2116798103 hasConceptScore W2116798103C121608353 @default.
• W2116798103 hasConceptScore W2116798103C126322002 @default.
• W2116798103 hasConceptScore W2116798103C142724271 @default.
• W2116798103 hasConceptScore W2116798103C143998085 @default.
• W2116798103 hasConceptScore W2116798103C204232928 @default.
• W2116798103 hasConceptScore W2116798103C2777421810 @default.
• W2116798103 hasConceptScore W2116798103C2778024521 @default.
• W2116798103 hasConceptScore W2116798103C2779306644 @default.
• W2116798103 hasConceptScore W2116798103C2780110267 @default.
• W2116798103 hasConceptScore W2116798103C530470458 @default.
• W2116798103 hasConceptScore W2116798103C71924100 @default.
• W2116798103 hasConceptScore W2116798103C74864618 @default.
• W2116798103 hasConceptScore W2116798103C84606932 @default.
• W2116798103 hasConceptScore W2116798103C86803240 @default.
• W2116798103 hasConceptScore W2116798103C98717036 @default.
• W2116798103 hasIssue "10" @default.
• W2116798103 hasLocation W21167981031 @default.
• W2116798103 hasLocation W21167981032 @default.
• W2116798103 hasLocation W21167981033 @default.
• W2116798103 hasLocation W21167981034 @default.

• next